Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The contribution of amyloid deposition in the aortic valve to calcification and aortic stenosis

The contribution of amyloid deposition in the aortic valve to calcification and aortic stenosis Calcific aortic valve disease (CAVD) and stenosis have a complex pathogenesis, and no therapies are available that can halt or slow their progression. Several studies have shown the presence of apolipoprotein-related amyloid deposits in close proximity to calcified areas in diseased aortic valves. In this Perspective, we explore a possible relationship between amyloid deposits, calcification and the development of aortic valve stenosis. These amyloid deposits might contribute to the amplification of the inflammatory cycle in the aortic valve, including extracellular matrix remodelling and myofibroblast and osteoblast-like cell proliferation. Further investigation in this area is needed to characterize the amyloid deposits associated with CAVD, which could allow the use of antisense oligonucleotides and/or isotype gene therapies for the prevention and/or treatment of CAVD. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nature Reviews Cardiology Springer Journals

The contribution of amyloid deposition in the aortic valve to calcification and aortic stenosis

Download PDF
11 pages

Loading next page...
 
/lp/springer-journals/the-contribution-of-amyloid-deposition-in-the-aortic-valve-to-Pv9uSU1CJ4

References (72)

Publisher
Springer Journals
Copyright
Copyright © Springer Nature Limited 2023. corrected publication 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
ISSN
1759-5002
eISSN
1759-5010
DOI
10.1038/s41569-022-00818-2
Publisher site
See Article on Publisher Site

Abstract

Calcific aortic valve disease (CAVD) and stenosis have a complex pathogenesis, and no therapies are available that can halt or slow their progression. Several studies have shown the presence of apolipoprotein-related amyloid deposits in close proximity to calcified areas in diseased aortic valves. In this Perspective, we explore a possible relationship between amyloid deposits, calcification and the development of aortic valve stenosis. These amyloid deposits might contribute to the amplification of the inflammatory cycle in the aortic valve, including extracellular matrix remodelling and myofibroblast and osteoblast-like cell proliferation. Further investigation in this area is needed to characterize the amyloid deposits associated with CAVD, which could allow the use of antisense oligonucleotides and/or isotype gene therapies for the prevention and/or treatment of CAVD.

Journal

Nature Reviews Cardiology – Springer Journals

Published: Jun 1, 2023

There are no references for this article.